Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism International News


July 1996

Vol 14 Issue 7/8 Follow-up: IFPMA rulings: "Unsurpassed" dishonesty. The IFPMA's decision on our complaint about Parke-Davis' promotion of Ponstan (mefenamic acid) for paediatric use in Pakistan. The claims were "unsurpassed efficacy compared to acetominophen (paracetamol) in fever control", "faster antipyretic action", "prolonged duration of action", "better tolerance" etc. Parke-Davis had earlier agreed to remove the claim of "better tolerance" but continued to endorse its other claims. The IFPMA ruling was that no breach of the Code had occurred and "The company points out that the phrase 'Unsurpassed efficacy ...' does not mean superiority, it means equivalence." Our letter in reply protests.



HS Int News index



Our members can see and make comments on this page.


  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Click to Register

(read more)

Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts

If there is something you don't like, please tell us. If you like our work, please tell others.

  • E-mail
  • LinkedIn
  • Digg
  • Facebook
  • FriendFeed
  • Google Bookmarks
  • MySpace
  • Reddit
  • Slashdot
  • StumbleUpon
  • Tumblr
  • Twitter
  • Yahoo! Bookmarks